Skip to main content
logo
Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.930
-0.005 (-0.09%)
Mar 5, 2026, 4:00 PM EST - Market closed

Molecular Partners AG Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.344.977.04189.69.759.34
Revenue Growth (YoY)
-94.33%-29.38%-96.29%1843.82%4.39%-54.16%
Gross Profit
0.344.977.04189.69.759.34
Selling, General & Admin
16.0617.5819.3622.2417.4511.6
Research & Development
41.548.648.7850.7555.7256.08
Other Operating Expenses
1.42-----
Total Operating Expenses
58.9966.1968.1572.9973.1767.67
Operating Income
-60.3-61.22-61.11116.61-63.42-58.33
Interest Income
4.867.214.281.860.190.37
Interest Expense
-4.8-0.04-5.16-0.62-0.56-4.82
Total Non-Operating Income (Expense)
0.067.18-0.881.24-0.37-4.45
Pretax Income
-60.23-54.04-61.98117.85-63.78-62.78
Provision for Income Taxes
--0---00.01
Net Income
-60.23-54.04-61.98117.85-63.79-62.76
Net Income to Common
-60.23-54.04-61.98117.85-63.79-62.76
Shares Outstanding (Basic)
373433323125
Shares Outstanding (Diluted)
373433333125
Shares Change (YoY)
12.45%3.85%-1.49%7.29%24.02%16.75%
EPS (Basic)
-1.62-1.59-1.893.63-2.06-2.51
EPS (Diluted)
-1.62-1.59-1.893.54-2.06-2.51
Free Cash Flow
-54.12-59.95-59.58117.39-91.89-30.43
Free Cash Flow Per Share
-1.46-1.76-1.823.53-2.96-1.22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-17708.08%-1231.73%-868.26%61.50%-650.17%-624.21%
Profit Margin
-17689.87%-1087.38%-880.70%62.16%-653.94%-671.70%
FCF Margin
-15893.10%-1206.30%-846.55%61.91%-942.03%-325.71%
EBITDA
-58.08-58.85-58.69119-60.85-55.44
EBITDA Margin
-17058.30%-1184.06%-833.87%62.76%-623.88%-593.31%
EBIT
-60.3-61.22-61.11116.61-63.42-58.33
EBIT Margin
-17708.08%-1231.73%-868.26%61.50%-650.17%-624.21%
Effective Tax Rate
-0.00%0.00%0.00%0.00%-0.02%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q